BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7030942)

  • 1. Potential anti-leprosy vaccine from killed ICRC bacilli--a clinicopathological study.
    Deo MG; Bapat CV; Chullawalla RG; Bhatki WS
    Indian J Med Res; 1981 Aug; 74():164-77. PubMed ID: 7030942
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal reaction in lepromatous patients induced by a vaccine containing killed ICRC bacilli--a report of five cases.
    Bhatki WS; Chulawala RG; Bapat CV; Deo MG
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):466-72. PubMed ID: 6368413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileprosy potentials of ICRC vaccine. A study in patients and healthy volunteers.
    Deo MG; Bapat CV; Bhalerao V; Chaturvedi RM; Bhatki WS; Chulawala RG
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):540-9. PubMed ID: 6368417
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of ICRC antileprosy vaccine in healthy subjects.
    Chaturvedi RM; Chirmule NB; Yellapurkar MV; Shaikh SU; Deo MG
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):657-66. PubMed ID: 3323368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization and reactogenicity of two doses of candidate antileprosy vaccine Mycobacterium w.
    Gupte MD; Vallishayee RS; Anantharaman DS; Britto RL; Nagaraju B
    Indian J Lepr; 1996; 68(4):315-24. PubMed ID: 9001899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leprosy.
    Rea TH; Modlin RL
    Immunol Ser; 1989; 46():723-45. PubMed ID: 2488876
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological properties of M. leprae culture isolates ICRC bacilli: hypothesis on relationship between M. leprae and ML-culture isolates.
    Bapat CV
    Acta Leprol; 1984; 2(2-4):175-94. PubMed ID: 6442820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lepromin conversion induced by a 'sub-unit' vaccine from ICRC bacilli.
    Bhatki WS; Chullawala RG; Chaturvedi RM; Dixit GM; Deo MG
    Indian J Med Res; 1988 Jun; 87():545-54. PubMed ID: 3071521
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leprosy vaccine--a puzzle.
    Job CK
    Lepr India; 1983 Jan; 55(1):1-7. PubMed ID: 6348409
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigeneic cross-reactivity between ICRC-bacilli and M. leprae--"in vitro" evaluation.
    Kale VP; Bapat CV
    Indian J Lepr; 1984; 56(2):219-31. PubMed ID: 6387004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELISA & lepromin skin tests in household contacts of leprosy patients.
    Dhandayuthapani S; Anandan D; Bhatia VN
    Indian J Med Res; 1990 Nov; 91():431-6. PubMed ID: 2091988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human vaccination studies in normal and contacts of leprosy patients.
    Samuel NM; Stanford JL; Rees RJ; Fairbairn T; Adiga RB
    Indian J Lepr; 1984; 56(1):36-47. PubMed ID: 6384380
    [No Abstract]   [Full Text] [Related]  

  • 15. ICRC 'anti-leprosy vaccine'.
    Deo MG
    Vaccine; 1989 Apr; 7(2):92-3. PubMed ID: 2665352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice.
    Jeevan A; Bapat CV
    Indian J Lepr; 1984; 56(4):754-63. PubMed ID: 6398339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
    Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
    Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A candidate anti-leprosy vaccine from ICRC bacilli.
    Deo MG; Chaturvedi RM; Kartikeyan S
    Trop Med Parasitol; 1990 Sep; 41(3):367-8. PubMed ID: 2255866
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
    Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of soluble, Mycobacterium leprae-derived antigen in the inflammatory exudate of reactional lepromatous leprosy.
    Rojas-Espinosa O; González-Mendoza A; Estrada-Parra S; Ortíz Y; González-Cruz O; Cornejo AL; Pérez-Suarez G
    Lepr Rev; 1985 Sep; 56(3):229-38. PubMed ID: 3903409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.